Advanced Search

Technical Analysis for TLIS - Talis Biomedical Corporation

Grade Last Price % Change Price Change
B 10.96 4.98% 0.52
TLIS closed up 4.98 percent on Wednesday, July 28, 2021, on 1.15 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Aug 10
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Down
Historical TLIS trend table...
Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Fell Below 20 DMA Bearish 4.98%
Fell Below 50 DMA Bearish 4.98%
Calm After Storm Range Contraction 4.98%
Multiple of Ten Bullish Other 4.98%
20 DMA Support Bullish 1.11%
50 DMA Support Bullish 1.11%
20 DMA Support Bullish -6.32%
50 DMA Support Bullish -6.32%
Older End-of-Day Signals for TLIS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 13 hours ago
Rose Above Previous Day's High about 13 hours ago
Rose Above 10 DMA about 13 hours ago
Up 5% about 13 hours ago
60 Minute Opening Range Breakout about 14 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

Talis Biomedical Corporation develops a diagnostic platform that offers senior care facilities and laboratory testing services. Talis Biomedical Corporation was formerly known as Talis Biomedical, Inc. and changed its name to Talis Biomedical Corporation in February 2018. The company was founded in 2010 and is based in Menlo Park, California with an additional office in Chicago, Illinois.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Lab Testing Information Science Diagnostics

Is TLIS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 27 Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021
May 12 Have Insiders Been Buying Talis Biomedical Corporation (NASDAQ:TLIS) Shares?
May 12 Talis Biomedical Corporation (TLIS) CEO Brian Coe on Q1 2021 Results - Earnings Call Transcript
May 11 Talis Biomedical EPS of -$4.61
May 11 Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress
May 11 Talis Biomedical Corp to Host Earnings Call
May 11 Earnings Scheduled For May 11, 2021
May 4 Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021
Apr 28 Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
Mar 26 The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
See more TLIS news...

Indicators

Indicator Value
52 Week High 33.9
52 Week Low 9.43
Average Volume 359,362
200-Day Moving Average 0.00
50-Day Moving Average 10.55
20-Day Moving Average 10.63
10-Day Moving Average 11.02
Average True Range 1.01
ADX 15.84
+DI 22.71
-DI 17.20
Chandelier Exit (Long, 3 ATRs) 9.80
Chandelier Exit (Short, 3 ATRs) 12.53
Upper Bollinger Bands 12.18
Lower Bollinger Band 9.08
Percent B (%b) 0.61
BandWidth 29.18
MACD Line 0.15
MACD Signal Line 0.10
MACD Histogram 0.0488
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.65
Resistance 3 (R3) 12.59 11.96 12.37
Resistance 2 (R2) 11.96 11.53 11.99 12.28
Resistance 1 (R1) 11.46 11.26 11.71 11.52 12.18
Pivot Point 10.83 10.83 10.96 10.86 10.83
Support 1 (S1) 10.33 10.40 10.58 10.40 9.74
Support 2 (S2) 9.70 10.13 9.73 9.64
Support 3 (S3) 9.20 9.70 9.55
Support 4 (S4) 9.27